What is QGEN's five-year median EV/EBITDA?

There are not enough weekly readings yet for a five-year median EV/EBITDA.

Does a low historical rank mean a stock is a buy?

No. The rank compares QGEN only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

QIAGEN NV (QGEN) valuation history

Health Care

$50.34

Latest weekly close · Market cap $10.4B

QIAGEN's EV/EBITDA of 15.3x does not have enough weekly history to rank yet (as of Oct 30, 2026).

Forward P/E 19.3× (analyst estimates, not ranked).

No EV/EBITDA chart for QGEN right now

QGEN has no weekly EV/EBITDA history to chart yet.

EV/EBITDA

n/mnot ranked

EV/EBITDA needs more weekly history to be ranked.

Growth, last 12 months vs the year before

Revenue: 0%
EPS: n/m

Health Care peers on EV/EBITDA

Each percentile compares a stock with its own last five years.

Compare QGEN with peers

Health Care peers of QGEN on EV/EBITDA
Stock	EV/EBITDA	Versus its own history	5-year percentile
AAgilent Technologies	28.0×	Historically high	94
AVTRAvantor Inc	16.1×	Within its usual range	36
BIOBio-Rad Laboratories Inc	n/m	Not ranked	n/m, not ranked
BRKRBruker Corp	55.5×	Historically high	99
CRLCharles River Laboratories	52.8×	Historically high	100

Appears in

Sector: Health Care
Screens: Nuclear Stocks: Valuation Screen
Semiconductor Equipment Stocks: Valuation Screen

Screen Health Care stocks the same way

Research on QGEN

No articles about QGEN yet. How valuation percentiles work

Loading peers and related research…

About this history

What is QGEN's current EV/EBITDA?: QIAGEN's EV/EBITDA of 15.3x does not have enough weekly history to rank yet (as of Oct 30, 2026).
What is QGEN's five-year median EV/EBITDA?: There are not enough weekly readings yet for a five-year median EV/EBITDA.
Does a low historical rank mean a stock is a buy?: No. The rank compares QGEN only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.